Evidence map›Paper›PMID 34533673›Full record

ArticleInflammation2021

Stellate Ganglion Block Improves the Proliferation and Function of Splenic CD4 + T Cells Through Inhibition of Posthemorrhagic Shock Mesenteric Lymph-Mediated Autophagy.

Ying Li, Hui-Bo Du, Li-Na Jiang, Chen Wang, Meng Yin, Li-Min Zhang, Hong Zhang, Zhen-Ao Zhao, Zhan-Kuang Liu, Chun-Yu Niu and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ying Li *Institute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Hui-Bo Du *Institute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Li-Na JiangInstitute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Chen WangInstitute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Meng YinInstitute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Li-Min ZhangInstitute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Hong ZhangInstitute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Zhen-Ao ZhaoInstitute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Zhan-Kuang LiuAffiliated First Hospital, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Chun-Yu NiuHebei Key Laboratory of Critical Disease Mechanism and Intervention, Shijiazhuang and Zhangjiakou, Diamond South Road 11, Zhangjiakou, Hebei, People's Republic of China. ncylxf@126.com.
Zi-Gang ZhaoInstitute of Microcirculation, Hebei North University, Zhangjiakou, Hebei, People's Republic of China. zzghyl@126.com.ORCID http://orcid.org/0000-0002-9434-5231
Hebei North University · CNHebei Medical University · CN

Funding

National Natural Science Foundation of China 81770492
6 · The paper itself

Abstract

Severe hemorrhagic shock leads to excessive inflammation and immune dysfunction, which results in high mortality related to mesenteric lymph return. A recent study showed that stellate ganglion block (SGB) increased the survival rate in rats suffering hemorrhagic shock. However, whether SGB ameliorates immune dysfunction induced by hemorrhagic shock remains unknown. The aim of the present study was to verify the favorable effects of SGB on the proliferation and function of splenic CD4 + T cells isolated from rats that underwent hemorrhagic shock and to investigate the mechanism related to the SGB interaction with autophagy and posthemorrhagic shock mesenteric lymph (PHSML). Male rats underwent SGB or sham SGB and conscious acute hemorrhage followed by resuscitation and multiple treatments. After 3 h of resuscitation, splenic CD4 + T cells were isolated to measure proliferation and cytokine production following stimulation with ConA in vitro. CD4 + T cells isolated from normal rats were treated with PHSML drained from SBG-treated rats, and proliferation, cytokine production, and autophagy biomarkers were detected. Hemorrhagic shock reduced CD4 + T cell proliferation and production of interleukin (IL)-2, IL-4, and tumor necrosis factor-α-induced protein 8-like 2 (TIPE2). SGB or administration of the autophagy inhibitor 3-methyladenine (3-MA) normalized these indicators. In contrast, administration of rapamycin (RAPA) autophagy agonist or intravenous injection of PHSML inhibited the beneficial effects of SGB on CD4 + T cells from hemorrhagic shocked rats. Furthermore, PHSML incubation decreased proliferation and cytokine production, increased LC3 II/I and Beclin-1 expression, and reduced p-PI3K and p-Akt expression in normal CD4 + T cells. These adverse effects of PHSML were also abolished by 3-MA administration, as well as incubation with PHSML obtained from SGB-treated rats. SGB improves splenic CD4 + T cell function following hemorrhagic shock, which is related to the inhibition of PHSML-mediated autophagy.

Indexed as

Autonomic Nerve BlockAutophagyCell ProliferationLymphocyte ActivationStellate GanglionAnimalsAutophagy-Related ProteinsCD4-Positive T-LymphocytesCells, CulturedCytokinesDisease Models, AnimalIntracellular Signaling Peptides and ProteinsLymphMaleMesenteryPhenotypeAutophagy-Related ProteinsCytokinesIntracellular Signaling Peptides and ProteinsTnfaip8l2 protein, ratAutophagyCD4 + T cellsHemorrhagic shockPosthemorrhagic shock mesenteric lymphSpleen.Stellate ganglion block

Identifiers

PMID34533673
OpenAlexW3182866579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.